Cytek Biosciences, Inc. (CTKB)
4.40
+0.06
(+1.38%)
USD |
NASDAQ |
Feb 20, 13:18
Cytek Biosciences EPS Diluted (Quarterly) : -0.043 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Standard BioTools, Inc. | -0.0906 |
| Ludwig Enterprises, Inc. | 0.00 |
| QHSLab, Inc. | 0.0017 |
| OpGen, Inc. | -0.0604 |
| Zomedica Corp. | -0.0062 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.478M |
| Revenue (Quarterly) | 52.29M |
| Total Expenses (Quarterly) | 57.77M |
| Enterprise Value | 328.36M |
| Gross Profit Margin (Quarterly) | 52.69% |
| Profit Margin (Quarterly) | -10.48% |
| Earnings Yield | -2.30% |
| Normalized Earnings Yield | -3.518 |